Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
S1226(8%)
DRUG
2 trials
Sponsors
SolAeroMed Inc.
Conditions
Asthma
Phase 1
Phase1, Placebo-Controlled, Randomized, Double-blind, Single-ascending Dose Study in Healthy Subjects.
Completed
NCT02616770
SolAeroMed Inc.
Asthma
Start: 2014-03-31
End: 2014-05-31
Updated: 2015-11-30
Phase 2
Single Dose Study to Evaluate the Safety, and Efficacy of S-1226 (8%) in Subjects With Mild Atopic Asthma
Completed
NCT02334553
SolAeroMed Inc.
Asthma
Start: 2015-02-06
End: 2015-11-25
Updated: 2019-02-18
Related Papers
A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma.
2018-06-18
9 citations
A phase I, placebo-controlled, randomized, double-blind, single ascending dose-ranging study to evaluate the safety and tolerability of a novel biophysical bronchodilator (S-1226) administered by nebulization in healthy volunteers
Trials
2016-07-27
11 citations